/ /

  • linkedin
  • Increase Font
  • Sharebar

    Is HPV testing ready for ‘prime’ time in cervical cancer detection?

     

     

    References

    1. U.S. Food and Drug Administration. FDA News Release: FDA approves first human papillomavirus test for primary cervical cancer screening. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm394773.htm. Accessed October 23, 2014.

    2. Ronco G, Dillner J, Elfstrom KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524–532.

    3. Wright TC, Stoler MH, Behrens CM et al. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 2012;206(1):46,e1-46.e11.

    4. Roche Molecular Systems, Inc. Cobas HPV Test Medical Devices Advisory Committee Microbiology Panel Meeting: Sponsor Executive Summary. http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/medicaldevices/medicaldevicesadvisorycommittee/microbiologydevicespanel/ucm388565.pdf. Accessed July 1, 2014.

    NEXT: No. More data are needed before the HPV test can stand alone >>

     

    Sarah Feldman, MD, MPH
    Dr. Feldman is Associate Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School, Director of Ambulatory ...
    Aparna Kamat, MD
    Dr. Kamat is the Director of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the Methodist Hospital, Houston, Texas.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    Latest Tweets Follow